Jessica Schubert
Forskare vid Institutionen för medicinska vetenskaper; Kardiologi
- E-post:
- jessica.schubert@medsci.uu.se
- Besöksadress:
- Akademiska sjukhuset, ingång 40, 5 tr
751 85 UPPSALA - Postadress:
- Akademiska sjukhuset, ingång 40, 5 tr
751 85 UPPSALA
Publikationer
Senaste publikationer
Atherogenic lipoproteins and lipid-lowering therapy in acute coronary syndrome
2025
Ingår i Journal of the American College of Cardiology, s. 1550-1564, 2025
- DOI för Early Ezetimibe Initiation After Myocardial Infarction Protects Against Later Cardiovascular Outcomes in the SWEDEHEART Registry
- Ladda ner fulltext (pdf) av Early Ezetimibe Initiation After Myocardial Infarction Protects Against Later Cardiovascular Outcomes in the SWEDEHEART Registry
Ingår i European Heart Journal, s. 4204-4215, 2024
- DOI för Intensive early and sustained lowering of non-high-density lipoprotein cholesterol after myocardial infarction and prognosis: the SWEDEHEART registry
- Ladda ner fulltext (pdf) av Intensive early and sustained lowering of non-high-density lipoprotein cholesterol after myocardial infarction and prognosis: the SWEDEHEART registry
Ingår i Journal of Internal Medicine, s. 616-627, 2023
- DOI för Elevated low-density lipoprotein cholesterol: An inverse marker of morbidity and mortality in patients with myocardial infarction
- Ladda ner fulltext (pdf) av Elevated low-density lipoprotein cholesterol: An inverse marker of morbidity and mortality in patients with myocardial infarction
Ingår i European Heart Journal, s. 243-252, 2021
- DOI för Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study
- Ladda ner fulltext (pdf) av Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study
Alla publikationer
Artiklar i tidskrift
Ingår i Journal of the American College of Cardiology, s. 1550-1564, 2025
- DOI för Early Ezetimibe Initiation After Myocardial Infarction Protects Against Later Cardiovascular Outcomes in the SWEDEHEART Registry
- Ladda ner fulltext (pdf) av Early Ezetimibe Initiation After Myocardial Infarction Protects Against Later Cardiovascular Outcomes in the SWEDEHEART Registry
Ingår i European Heart Journal, s. 4204-4215, 2024
- DOI för Intensive early and sustained lowering of non-high-density lipoprotein cholesterol after myocardial infarction and prognosis: the SWEDEHEART registry
- Ladda ner fulltext (pdf) av Intensive early and sustained lowering of non-high-density lipoprotein cholesterol after myocardial infarction and prognosis: the SWEDEHEART registry
Ingår i Journal of Internal Medicine, s. 616-627, 2023
- DOI för Elevated low-density lipoprotein cholesterol: An inverse marker of morbidity and mortality in patients with myocardial infarction
- Ladda ner fulltext (pdf) av Elevated low-density lipoprotein cholesterol: An inverse marker of morbidity and mortality in patients with myocardial infarction
Ingår i European Heart Journal, s. 243-252, 2021
- DOI för Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study
- Ladda ner fulltext (pdf) av Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study
Ingår i European Heart Journal - Quality of Care and Clinical Outcomes, s. 59-67, 2021
- DOI för Low-density lipoprotein-cholesterol target attainment according to the 2011 and 2016 ESC/EAS dyslipidaemia guidelines in patients with a recent myocardial infarction: nationwide cohort study, 2013–17
- Ladda ner fulltext (pdf) av Low-density lipoprotein-cholesterol target attainment according to the 2011 and 2016 ESC/EAS dyslipidaemia guidelines in patients with a recent myocardial infarction: nationwide cohort study, 2013–17
Risk Factors for Carbamazepine Induced Serious Skin Reactions
Ingår i Pharmacoepidemiology and Drug Safety, s. 441-441, 2012